Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BOD.AU
- Price
- 0.02
- Stock movement up
- +- (%)
- Company name
- Bod Science Limited
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 4.26M
- Ent value
- 11.45M
- Price/Sales
- 1.34
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -19.43%
- 1 year return
- -
- 3 year return
- -49.83%
- 5 year return
- -36.36%
- 10 year return
- -
Last updated: 2025-04-08
DIVIDENDS
BOD.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.34 |
| Price to Book | - |
| EV to Sales | 3.60 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 177.34M |
| EPS (TTM) | -0.06 |
| FCF per share (TTM) | -0.02 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.18M |
| Gross profit (TTM) | 96.81K |
| Operating income (TTM) | -6.77M |
| Net income (TTM) | -11.19M |
| EPS (TTM) | -0.06 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 3.05% |
| Operating margin (TTM) | -213.12% |
| Profit margin (TTM) | -352.17% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 434.40K |
| Net receivables | 213.32K |
| Total current assets | 2.28M |
| Goodwill | 0.00 |
| Intangible assets | 21.71K |
| Property, plant and equipment | 0.00 |
| Total assets | 2.31M |
| Accounts payable | 4.27M |
| Short/Current long term debt | 1.83M |
| Total current liabilities | 7.58M |
| Total liabilities | 7.63M |
| Shareholder's equity | -5.32M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.61M |
| Capital expenditures (TTM) | 88.21K |
| Free cash flow (TTM) | -3.70M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -485.26% |
| Return on Invested Capital | 320.98% |
| Cash Return on Invested Capital | 106.14% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.02 |
| Daily high | 0.02 |
| Daily low | 0.02 |
| Daily Volume | 0K |
| All-time high | 0.67 |
| 1y analyst estimate | - |
| Beta | 1.46 |
| EPS (TTM) | -0.06 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 8 Apr 2025 |
Downside potential
Loading...
Downside potential data
| BOD.AU | S&P500 | |
| Current price drop from All-time high | -96.42% | -17.71% |
| Highest price drop | -96.42% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -59.17% | -11.07% |
| Avg time to new high | 129 days | 12 days |
| Max time to new high | 1438 days | 1805 days |
COMPANY DETAILS
Marketcap
4.26M
Marketcap category
Small-cap
Description
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets. The company provides Flexofytol, an anti-inflammatory derived from a scientifically validated and clinically trialed turmeric extract that helps in improving joint pain and stiffness, joint health, limiting the ageing of cartilage, and reducing inflammation caused by mild arthritis; and Sedistress, a passion flower extract that reduces the symptoms of stress, anxiety, and insomnia, as well as contract manufacturing services. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Double Bay, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found